ASLAN Pharmaceuticals Lim...

NASDAQ: ASLN · Real-Time Price · USD
0.60
-0.10 (-14.27%)
At close: Jul 18, 2024, 10:00 PM

ASLAN Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period Ending Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022
Net Income
-9.71M -1.87M -19.11M -14.48M -10.93M
Depreciation & Amortization
n/a n/a n/a -2.37M n/a
Stock-Based Compensation
n/a n/a n/a 336.25K n/a
Other Working Capital
n/a n/a n/a 103.78M n/a
Other Non-Cash Items
9.71M 1.87M 19.11M 14.48M 10.93M
Deferred Income Tax
n/a n/a n/a -108.51M n/a
Change in Working Capital
n/a n/a n/a 104.3M n/a
Operating Cash Flow
n/a n/a n/a -6.24M n/a
Capital Expenditures
n/a n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a -30.21K n/a
Investing Cash Flow
n/a n/a n/a -30.21K n/a
Debt Repayment
n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a 9.11M n/a
Financial Cash Flow
n/a n/a n/a 9.11M n/a
Net Cash Flow
-124.81K -16.55M 594.46K -850.75K -3.82M
Free Cash Flow
n/a n/a n/a -6.24M n/a